Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Efalizumab> ?p ?o. }
Showing items 1 to 60 of
60
with 100 items per page.
- Efalizumab abstract "Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection. Efalizumab binds to the CD11a subunit of lymphocyte function-associated antigen 1 and acts as an immunosuppressant by inhibiting lymphocyte activation and cell migration out of blood vessels into tissues. Efalizumab was associated with fatal brain infections and was withdrawn from the market in 2009.Known side effects include bacterial sepsis, viral meningitis, invasive fungal disease and progressive multifocal leukoencephalopathy (PML), a brain infection caused by reactivation of latent JC virus infection. Four cases of PML were reported in plaque psoriasis patients, an incidence of approximately one in 500 treated patients.Due to the risk of PML, the European Medicines Agency and the FDA recommended suspension from the market in the European Union and the United States, respectively. In April 2009, Genentech Inc. announced a phased voluntary withdrawal of Raptiva from the U.S. market.".
- Efalizumab atcPrefix "L04".
- Efalizumab atcSuffix "AA21".
- Efalizumab casNumber "214745-43-4".
- Efalizumab drugbank "DB00095".
- Efalizumab fdaUniiCode "XX2MN88N5D".
- Efalizumab wikiPageID "5310787".
- Efalizumab wikiPageRevisionID "540946447".
- Efalizumab atcPrefix "L04".
- Efalizumab atcSuffix "AA21".
- Efalizumab casNumber "214745".
- Efalizumab chembl "1201575".
- Efalizumab chemspiderid "NA".
- Efalizumab drugbank "DB00095".
- Efalizumab hasPhotoCollection Efalizumab.
- Efalizumab mabType "mab".
- Efalizumab meltingPoint "66".
- Efalizumab routesOfAdministration "subcutaneous injection".
- Efalizumab source "zu/o".
- Efalizumab target CD11a.
- Efalizumab tradename "Raptiva".
- Efalizumab type "mab".
- Efalizumab unii "XX2MN88N5D".
- Efalizumab verifiedfields "changed".
- Efalizumab verifiedrevid "461092863".
- Efalizumab subject Category:Immunosuppressants.
- Efalizumab subject Category:Recombinant_proteins.
- Efalizumab subject Category:Withdrawn_drugs.
- Efalizumab type Agent114778436.
- Efalizumab type CausalAgent100007347.
- Efalizumab type Drug103247620.
- Efalizumab type Immunosuppressant103562958.
- Efalizumab type Immunosuppressants.
- Efalizumab type Matter100020827.
- Efalizumab type Medicine103740161.
- Efalizumab type PhysicalEntity100001930.
- Efalizumab type Substance100020090.
- Efalizumab type WithdrawnDrugs.
- Efalizumab type Drug.
- Efalizumab type DrugProduct.
- Efalizumab type FunctionalSubstance.
- Efalizumab comment "Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -zumab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection.".
- Efalizumab label "Efalizumab".
- Efalizumab label "Efalizumab".
- Efalizumab label "Efalizumab".
- Efalizumab label "Efalizumab".
- Efalizumab label "Efalizumab".
- Efalizumab label "إيفاليزوماب".
- Efalizumab label "依法利珠单抗".
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs Efalizumab.
- Efalizumab sameAs m.0ddw7w.
- Efalizumab sameAs Q418270.
- Efalizumab sameAs Q418270.
- Efalizumab sameAs DB00095.
- Efalizumab sameAs Efalizumab.
- Efalizumab wasDerivedFrom Efalizumab?oldid=540946447.
- Efalizumab isPrimaryTopicOf Efalizumab.